Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 19, 2026

Welcome to The Brain Health Minute, where science meets action, one minute at a time.

  • Wellness for MS
    /
The Brain Health Minute focuses on evidence-based lifestyle strategies that promote optimal brain health across the lifespan. Each episode highlights…
Wellness for MS

February 18, 2026

Predictors of initiating high-efficacy vs. platform therapies as first-line disease-modifying treatment in multiple sclerosis

  • MS Drug Therapies
    /
ORIGINAL RESEARCH article Front. Neurol., 29 January 2026 – Sec. Multiple Sclerosis and Neuroimmunology Volume 17 – 2026 | https://doi.org/10.3389/fneur.2026.1738815 Abstract…
MS Drug Therapies

February 16, 2026

Expert Panel Publishes Revised Consensus Recommendations for Diagnosis and Management of NMOSD

  • AutoImmune Diseases
    /
  • NMOSD
    /
  • MOGAD
    /
November 2025 Key Takeaways SHOW MORE In a newly published study, researchers developed expert-driven, evidence-based, up-to-date consensus recommendations for managing…
AutoImmune Diseases

February 16, 2026

REFRAMING MS

  • MS Injectable (Injection) Treatments
    /
  • MS Drug Therapies
    /
AN RMS TREATMENT ON YOUR TERMS Why Choose Kesimpta for an MS Therapy? KESIMPTA® is the only B-cell treatment you…
MS Injectable (Injection) Treatments

February 16, 2026

Natalizumab-sztn is an FDA-approved monotherapy for all indications of the reference product natalizumab, including relapsing forms of multiple sclerosis and Crohn disease.

  • MS Infusion Treatments
    /
  • MS Drug Therapies
    /
More than 2 years after its original approval, Sandoz’ natalizumab (Tyruko) biosimilar is officially available to patients with multiple sclerosis…
MS Infusion Treatments

February 16, 2026

Do you Know about the 2-TIMES-A-YEAR* OCREVUS and its AVAILABILITY for treating RMS and PPMS TWO different ways?

  • MS Infusion Treatments
    /
  • MS Injectable (Injection) Treatments
    /
  • MS Drug Therapies
    /
As a ~10-minute† subcutaneous injection OR as a 4-hour†/2-hour†‡ intravenous infusion To Learn More, click here: www.ocrevus.com…
MS Infusion Treatments

February 13, 2026

How Does Alcohol Affect MS?

  • MS Research Study and Reports
    /
By Crystal Hoshaw – Published on January 23, 2026Medically Reviewed by Barbara S. Giesser, MD, FAAN, FANA, Dipl. ABLM Note:…
MS Research Study and Reports
Featured image for “Sex, Intimacy, and Multiple Sclerosis”

February 10, 2026

Sex, Intimacy, and Multiple Sclerosis

  • Marketing
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Wellness for MS
    /
February 2026 Sexual relations are a sensitive — and difficult — topic for people with multiple sclerosis (MS), just as…
Marketing

February 9, 2026

ACTRIMS 2026: Blocking C3 protein seen to ease MS severity in older mice

  • MS Research Study and Reports
    /
Complement system own to reduce disease severity in older mice Written by Lila Levinson, PhD | February 9, 2026 The complement system —…
MS Research Study and Reports

February 9, 2026

Mental ill-health in MS: prevalence and causes

  • MS Cognition
    /
  • Memory (Cognition)
    /
  • Mental Health
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Anxiety & Depression
    /
February 2026 – by Prof. Gavin Giovannoni It is now well established that the burden of MS extends far beyond…
MS Cognition

Categories

Latest Blog Posts